Boehringer Ingelheim Sp. z o.o. is a pharmaceutical company located in Warsaw, Poland. It was established in 1993 and is a subsidiary of the global pharmaceutical group Boehringer Ingelheim. The company is engaged in research and development, production, and sales of innovative therapeutic products for human and veterinary medicine. Boehringer Ingelheim is committed to social responsibility and is involved in various social projects, such as the global project Making More Health, as well as providing equal opportunities for its employees. The company's main focus is on prescription drugs for humans and animals, and it also offers veterinary medicines and dietary supplements. In 2017, Boehringer Ingelheim reported net sales of approximately 18.1 billion euros, with 17% of the net sales invested in research and development. The company's headquarters are located in Ingelheim, Germany.
Headquarters
Ul. Jozefa Piusa Dziekonskiego 3
Warsaw; Mazowieckie;
Postal Code: 00-728
Contact Details: Purchase the Boehringer Ingelheim Sp. z o.o. report to view the information.
Website: http://www.boehringer-ingelheim.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service